Brian Lang

As an eight-year-old, Brian made and sold candles door to door. As an adult with a chronic entrepreneur addiction he helped a boutique music label grow to a national brand in the 80s, launched a successful Internet startup in the dot-com era, and today connects best-of-breed health and medtech startups with leading large healthcare organizations to accelerate innovation. He annually runs the coaching for companies competing in Austin's SXSW Accelerator - and when not working, he spoils his grandkids.

Google Cloud comes through

By Brian Lang / August 26, 2016

Recently, we had some trouble with the cloud services from Google one of our primary cloud vendors. In response, I wrote this very strongly worded blog post on my personal blog. Then we tweeted. Within four hours, Google had restored our services, and within a few hours of that, we were able to run down…

Read More

Houston Health IT Startups Part of Biden’s Cancer Moonshot Initiative

By Brian Lang / June 29, 2016

Houston—Two Houston health IT startups are among the private companies enlisted by U.S. Vice President Joe Biden in his national cancer moonshot initiative, designed to speed up efforts that could cure cancer. DocGraph and CareSet Systems, both based in Houston, are developing a cancer dataset that would contain summarized information on nearly a million Medicare…

Read More

CareSet sister company DocGraph to release the most accurate data picture to date of how cancer is treated by Medicare

By Brian Lang / June 29, 2016

WASHINGTON — Health data scientist Fred Trotter joined Vice President Joe Biden and other national healthcare leaders today for the invitation-only National Cancer Moonshot Summit. The Vice President announced that Trotter’s company, DocGraph, will release an open cancer dataset this year. The new dataset contains summarized information about almost a million Medicare cancer patients and more than…

Read More

Perspective: From a Data Parasite

By Brian Lang / February 27, 2015

I guess I qualify as a research parasite, according to the recent editorialpublished in the New England Journal of Medicine (NEJM). The controversy that followed led to a subsequent “non-apology,” a term I use because NEJM did not offer a shift in their stance as much as they tried to slink out of the spotlight.…

Read More